NO891220D0 - Middel som inneholder salicylsyre for behandling av lepidose. - Google Patents

Middel som inneholder salicylsyre for behandling av lepidose.

Info

Publication number
NO891220D0
NO891220D0 NO1989891220A NO891220A NO891220D0 NO 891220 D0 NO891220 D0 NO 891220D0 NO 1989891220 A NO1989891220 A NO 1989891220A NO 891220 A NO891220 A NO 891220A NO 891220 D0 NO891220 D0 NO 891220D0
Authority
NO
Norway
Prior art keywords
salicylic acid
treating
lepidose
composition containing
containing salicylic
Prior art date
Application number
NO1989891220A
Other languages
English (en)
Other versions
NO175885C (no
NO891220L (no
NO175885B (no
Inventor
Konrad Minninger
David Tang
Rainer Oberhagemann
Original Assignee
Konrad Minninger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konrad Minninger filed Critical Konrad Minninger
Publication of NO891220D0 publication Critical patent/NO891220D0/no
Publication of NO891220L publication Critical patent/NO891220L/no
Publication of NO175885B publication Critical patent/NO175885B/no
Publication of NO175885C publication Critical patent/NO175885C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
NO891220A 1987-07-25 1989-03-20 Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling NO175885C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3724691A DE3724691C2 (de) 1987-07-25 1987-07-25 Pharmazeutisches Mittel zur lokalen Therapie von schuppenden Hautkrankheiten
PCT/EP1988/000649 WO1989000853A1 (en) 1987-07-25 1988-07-19 Agent containing salicylic acid for treating lepidosis

Publications (4)

Publication Number Publication Date
NO891220D0 true NO891220D0 (no) 1989-03-20
NO891220L NO891220L (no) 1989-03-20
NO175885B NO175885B (no) 1994-09-19
NO175885C NO175885C (no) 1994-12-28

Family

ID=6332361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891220A NO175885C (no) 1987-07-25 1989-03-20 Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling

Country Status (9)

Country Link
EP (1) EP0325628B1 (no)
JP (1) JPH02500106A (no)
AT (1) ATE69550T1 (no)
AU (1) AU2072088A (no)
DE (2) DE3724691C2 (no)
DK (1) DK173547B1 (no)
FI (1) FI94314C (no)
NO (1) NO175885C (no)
WO (1) WO1989000853A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001303B (el) * 1989-01-23 1993-07-30 Wolff Chem Pharm Gmbh Μεθοδος παρασκευης μεσου που περιεχει σαλικυλικο οξυ εναντιον απολεπιστικων νοσων της επιδερμιδας.
ATE91079T1 (de) * 1989-01-25 1993-07-15 Wolff Chem Pharm Gmbh Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
GB9223034D0 (en) * 1992-11-03 1992-12-16 Surtech Int Ltd Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis
SE9403541L (sv) * 1994-10-14 1996-04-15 Sven Moberg Antimikrobiell komposition
US5736580A (en) * 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
ES2245465T3 (es) * 1996-09-18 2006-01-01 Applied Genetics Incorporated Dermatics Dioles de compuestos de norborneno y norbornano para el tratamiento de trastornos de la pigmentacion, enfermedades neurodegenerativas o enfermedades proliferativas de la piel.
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
DE10205193A1 (de) * 2002-02-08 2003-08-21 Beiersdorf Ag Diolhaltige Reinigungszubereitungen
DE10341179A1 (de) † 2003-09-06 2005-03-31 Beiersdorf Ag Wirkstoffkombination gegen Akne
WO2013093823A2 (en) 2011-12-20 2013-06-27 Vyome Biosciences Pvt Ltd Topical oil composition for the treatment of fungal infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE762726C (de) * 1942-05-02 1952-09-15 Hydrierwerke A G Deutsche Loesungsmittel bzw. Loesungsvermittler fuer Salicylsaeure
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
FR2585575B1 (fr) * 1985-08-01 1989-03-03 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique

Also Published As

Publication number Publication date
DK137589D0 (da) 1989-03-21
WO1989000853A1 (en) 1989-02-09
DE3724691A1 (de) 1989-02-02
FI891357A (fi) 1989-03-22
ATE69550T1 (de) 1991-12-15
AU2072088A (en) 1989-03-01
JPH02500106A (ja) 1990-01-18
NO175885C (no) 1994-12-28
DE3866344D1 (de) 1992-01-02
EP0325628B1 (de) 1991-11-21
FI94314C (fi) 1995-08-25
EP0325628A1 (de) 1989-08-02
DK173547B1 (da) 2001-02-19
FI891357A0 (fi) 1989-03-22
NO891220L (no) 1989-03-20
FI94314B (fi) 1995-05-15
DK137589A (da) 1989-05-19
DE3724691C2 (de) 1999-03-18
NO175885B (no) 1994-09-19

Similar Documents

Publication Publication Date Title
MY101791A (en) New benzimidazole derivatives
DE3486235D1 (de) Fettsäure-Zusammensetzungen.
JPS6470457A (en) Local remedy for skin damaged by beam
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
SE8402551L (sv) Cinnamoylmoranolin-derivat
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
DK581185D0 (da) Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
NO891220D0 (no) Middel som inneholder salicylsyre for behandling av lepidose.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DE69419981D1 (de) Retinoid enthaltendes Mittel
ES2051827T3 (es) Una composicion farmaceutica que contiene aceite de ricino polietoxilado.
GR900100612A (en) Compositions for local use
JPS6434909A (en) Cosmetic
MY103079A (en) New ophtalmological composition of matter
GB2021409A (en) Pharmaceutical composition
ATE22005T1 (de) Cremegrundlage.
KR880010762A (ko) 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers)
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
BE893025A (fr) Derives de l'acide 1,4-thiazane-carboxilique leurs preparation et utilisation ainsi que les compositions contenant ces derives.
ATE36718T1 (de) Glykosaminoglykane verwendbar in kosmetologie.
DK138191D0 (da) Salicylsyreholdigt middel til behandling af afskallende hudlidelser
KR890001556A (ko) 약제학적 조성물
SU1166370A1 (ru) Антигельминтное средство
IT1211765B (it) Formulazioni idrosolubili di ubidecarenoni,procedimento per la loro preparazione e composizioni cosmetiche che li contengono

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees